Psychophysics: Quantitative Sensory Testing in the Diagnostic Work-Up of Small Fiber Neuropathy

Sommer, Claudia

doi:10.1007/978-981-13-3546-4_4

Cited by 2 publications

(1 citation statement)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Psychophysics are used in pain research to explore how people perceive sensory stimuli (Price et al, 2001 ). A variety of stimuli have been used to induce pain in psychophysics research in adults with dementia, including mechanical pressure (Cole et al., 2006 ), electrical shock (Benedetti et al., 2004 ) and heat or cold (Sommer, 2019 ).…”

Section: Introductionmentioning

confidence: 99%

Treating the most vulnerable: A discursive review of experimental pain in Alzheimer’s disease

et al. 2021

View full text Add to dashboard Cite

The purpose of this discursive manuscript is to review three distinct studies that used very similar research methods, allowing the results to be critically compared. Following a series of three fictional vignettes describing various clinical scenarios managing pain, we introduce the reader to the research method of pain psychophysics.Next, we discuss how the three research studies described compliment and contrast one another. The discursive review format offers nurses an overview of a research method seldom used by nursing scientists. Psychophysical experiments allow a unique opportunity to examine the neurobiology and psychology of the pain experience in people with dementia.

show abstract

Section: Introductionmentioning

confidence: 99%

Treating the most vulnerable: A discursive review of experimental pain in Alzheimer’s disease

et al. 2021

View full text Add to dashboard Cite

show abstract

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Soejitno,

Widyadharma

2024

Egypt J Neurol Psychiatry Neurosurg

View full text Add to dashboard Cite

Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating condition of peripheral nerve because of chemotherapeutic agent exposure among cancer patients. Despite its relatively high prevalence, to date, there has been no specific or standardized diagnostic criteria for CIPN and establishing diagnosis can be burdensome with significant time and efforts. Therefore, there is a need for an accurate biomarker to aid in early and objective diagnosis of CIPN. Based on the relevant pathogenesis of CIPN, herein we discussed several potential biomarker candidates to be incorporated in the diagnosis of CIPN, ranging from bodily fluid-based biomarker such as neurotrophic factors and neurofilaments, genetic biomarker such as microRNAs, electrophysiologic biomarker such as quantitative sensory testing, and imaging biomarkers such as high-resolution ultrasound and magnetic resonance neurography. We also discussed the strengths and weaknesses of each biomarker type, and future directions to accelerate its translation into routine use in clinical practice.

show abstract

Psychophysics: Quantitative Sensory Testing in the Diagnostic Work-Up of Small Fiber Neuropathy

Cited by 2 publications

References 72 publications

Treating the most vulnerable: A discursive review of experimental pain in Alzheimer’s disease

Treating the most vulnerable: A discursive review of experimental pain in Alzheimer’s disease

Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials

Contact Info

Product

Resources

About